Moxifloxacin Is Efficacious for Treatment of Community-Acquired Lung Abscesses in Adults
Author(s) -
Hari Polenakovik,
Steven D. Burdette,
S. Polenakovik
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/432626
Subject(s) - moxifloxacin , medicine , lung , lung abscess , intensive care medicine , antibacterial agent , surgery , antibiotics , microbiology and biotechnology , biology
grounds for exclusion of those studies” [8, section 6.10]. Our 11 criteria were determined under the assumption that failure to meet just 1 criterion could potentially invalidate an entire study. The Cochrane Handbook continues with the statement that “if reviewers raise the methodological cut-point for including studies, there will be less variation in validity among the included reports” [8, section 6.10]. Metaanalysis was not attempted in our review, because only 2 studies were deemed experimentally sound. With regard to vitamin C, the purpose of our study was not to review vitamin C studies and their validity. The studies of Diehl [9], Hayden et al. [10], and Chalmers [11] were cited in our review [3] to show the importance of proof of blinding and to demonstrate the placebo effect in action. The importance of proof of blinding has been established as a vital component of experimental design. The Cochrane Handbook states “there is empirical evidence suggesting that...lack of double blinding results in overestimates of the effects of treatment” [8, section 6.11]. We stand by the results reported in our review.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom